نتایج جستجو برای: ژن cyp2d6

تعداد نتایج: 18157  

Journal: :British journal of clinical pharmacology 2015
Daniel L Hertz Anna C Snavely Howard L McLeod Christine M Walko Joseph G Ibrahim Steven Anderson Karen E Weck Gustav Magrinat Oludamilola Olajide Susan Moore Rachel Raab Daniel R Carrizosa Steven Corso Garry Schwartz Jeffrey M Peppercorn James P Evans David R Jones Zeruesenay Desta David A Flockhart Lisa A Carey William J Irvin

AIMS A prospectively enrolled patient cohort was used to assess whether the prediction of CYP2D6 phenotype activity from genotype data could be improved by reclassification of diplotypes or alleles. METHODS Three hundred and fifty-five patients receiving tamoxifen 20 mg were genotyped for CYP2D6 and tamoxifen metabolite concentrations were measured. The endoxifen : N-desmethly-tamoxifen metab...

Journal: :Anesthesiology 2005
Keith A Candiotti David J Birnbach David A Lubarsky Fani Nhuch Aimee Kamat Walter H Koch Michele Nikoloff Lin Wu David Andrews

BACKGROUND Some patients treated with ondansetron for postoperative nausea and vomiting do not respond to therapy. One possible mechanism for this failure is ultrarapid drug metabolism via the cytochrome P-450 system, specifically the enzyme 2D6 (CYP2D6). Ultrarapid metabolism is seen in patients with multiple functional copies (>/= 3) of the CYP2D6 allele. This study was designed to determine ...

2013
Ulrike M. Stamer Lan Zhang Malte Book Lutz E. Lehmann Frank Stuber Frank Musshoff

BACKGROUND The impact of polymorphic cytochrome P450 CYP2D6 enzyme on oxycodone's metabolism and clinical efficacy is currently being discussed. However, there are only spare data from postoperative settings. The hypothesis of this study is that genotype dependent CYP2D6 activity influences plasma concentrations of oxycodone and its metabolites and impacts analgesic consumption. METHODS Patie...

Journal: :BioTechniques 2005
Pedro Dorado Macarena Cáceres Eulalia Pozo-Guisado Ma-Li Wong Julio Licinio Adrián Llerena

There is growing consensus on the potential use of pharmacogenetics in clinical practice, and hopes have been expressed for application to the improvement of global health. However, two major challenges may lead to widening the "biotechnological gap" between the developing and the industrial world; first the unaffordability of some current technologies for poorer countries, and second the neces...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2002
Barbara J Ring Jennifer S Gillespie James A Eckstein Steven A Wrighton

Studies were performed to determine the human enzymes responsible for the biotransformation of atomoxetine to its major metabolite, 4-hydroxyatomoxetine, and to a minor metabolite, N-desmethylatomoxetine. Utilizing human liver microsomes containing a full complement of cytochrome P450 (P450) enzymes, average K(m) and CL(int) values of 2.3 microM and 103 microl/min/mg, respectively, were obtaine...

Journal: :The Journal of pharmacology and experimental therapeutics 2003
Ai-Ming Yu Jeffrey R Idle Kristopher W Krausz Adrian Küpfer Frank J Gonzalez

The psychotropic beta-carboline alkaloids, showing high affinity for 5-hydroxytryptamine, dopamine, benzodiazepine, and imidazoline receptors and the stimulation of locus coeruleus neurons, are formed endogenously from tryptophan-derived indolealkylamines through the Pictet-Spengler condensation with aldehydes in both plants and mammals. Cytochromes P450 1A1 (18.5), 1A2 (20), and 2D6 (100) cata...

Journal: :Clinical chemistry 2003
Birgitte Wuyts Dirk Bernard Nele Van den Noortgate Johan Van de Walle Bruno Van Vlem Rita De Smet Frank De Geeter Raymond Vanholder Joris R Delanghe

ously (7 ), and confirmed the proposed CYP2D6*35 haplotype (10 ). Phenotype-genotype correlation analysis subsequently showed that poor metabolizer status could effectively be ruled out by positive identification of a single functional 1584G-containing allelic variant in 43% of Caucasians but only 12% of African Americans. The 1584G assay can be performed directly on genomic DNA or on a long CY...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2007
Hongwu Shen Minxia M He Houfu Liu Steven A Wrighton Li Wang Bin Guo Chuan Li

Polymorphisms in the cytochrome P450 2D6 (CYP2D6) gene are a major cause of pharmacokinetic variability in human. Although the poor metabolizer phenotype is known to be caused by two null alleles leading to absence of functional CYP2D6 protein, the large variability among individuals with functional alleles remains mostly unexplained. Thus, the goal of this study was to examine the intrinsic en...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2000
H Dong R L Haining K E Thummel A E Rettie S D Nelson

Acetaminophen (APAP), a widely used analgesic and antipyretic agent, can cause acute hepatic necrosis in both humans and experimental animals when consumed in large doses. It is generally accepted that N-acetyl-p-benzoquinone imine (NAPQI) is the toxic, reactive intermediate whose formation from APAP is mediated by cytochrome P450. Several forms of P450 in humans, including 2E1, 1A2, 2A6, 3A4, ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2000
T Schulz-Utermoehl R J Edwards A R Boobis

A series of antipeptide antibodies directed against CYP2D6 were produced by immunizing rabbits with peptides that were sterically unrestrained (linear) or conformationally restricted by cyclization. A variety of sites within the region comprising residues 254 to 290 of CYP2D6 were targeted. In immunoblotting studies, each of the antibodies against the linear and cyclic peptides recognized only ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید